Suppr超能文献

自杀未遂后自杀预测中地塞米松抑制试验阈值的ROC分析。

ROC analysis of dexamethasone suppression test threshold in suicide prediction after attempted suicide.

作者信息

Jokinen Jussi, Nordström Anna-Lena, Nordström Peter

机构信息

Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institutet, Karolinska University Hospital, Solna, SE-171 76 Stockholm, Sweden.

出版信息

J Affect Disord. 2008 Feb;106(1-2):145-52. doi: 10.1016/j.jad.2007.06.008. Epub 2007 Jul 27.

Abstract

Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis function is associated with suicidal behavior. In suicide attempters with mood disorder, the non-suppressor status in the dexamethasone suppression test (DST) is associated with suicide indicating that HPA-axis hyperactivity is a biological risk factor for suicide and may be a useful predictor. The threshold of 5 microg/dl for cortisol levels measured at 08:00 a.m. or 4:00 p.m. following dexamethasone at 11:00 p.m. to define the DTS nonsuppression was derived as being optimal for the separation of melancholia and nonmelancholic conditions rather than the prediction of suicide. A different threshold may offer a better identification of suicide. The aim of this study was to find the optimal threshold level of post DST plasma cortisol at 4 p.m. for suicide prediction using receiver operating characteristics (ROC) analysis. A cohort of 106 depressed inpatients with an index suicide attempt admitted to the department of Psychiatry at the Karolinska University Hospital between 1980 and 2000, were submitted to DST and followed up for causes of death. During the follow-up (mean 17 years), 25 suicides (24%) were identified. The ROC analysis revealed that a lower threshold of 3.3 microg/dl for the nonsuppressor status predicted 17 of 25 suicides (sensitivity of 68%) compared with 15 of 25 suicides (sensitivity 60%) with a conventional threshold of 5 microg/dl at 4:00 p.m. In male suicide attempters the lower threshold for pathological DST result (3.3 microg/dl) changed the Odds ratio from 6.7 till 18. In female suicide attempters a higher threshold (7.3 microg/dl) optimised the value of DST as a biological test for suicide prediction indicating a gender difference.

摘要

下丘脑 - 垂体 - 肾上腺(HPA)轴功能失调与自杀行为有关。在患有情绪障碍的自杀未遂者中,地塞米松抑制试验(DST)中的非抑制状态与自杀相关,这表明HPA轴功能亢进是自杀的一个生物学危险因素,并且可能是一个有用的预测指标。晚上11点给予地塞米松后,上午8点或下午4点测量的皮质醇水平5微克/分升的阈值被确定为区分忧郁症和非忧郁症状态的最佳值,而非用于预测自杀。不同的阈值可能会更好地识别自杀行为。本研究的目的是使用受试者工作特征(ROC)分析来找出下午4点DST后血浆皮质醇用于自杀预测的最佳阈值水平。1980年至2000年间,卡罗林斯卡大学医院精神病科收治的106名有过自杀未遂的抑郁症住院患者接受了DST检查,并对其死因进行了随访。在随访期间(平均17年),确定有25人(24%)自杀。ROC分析显示,对于非抑制状态,较低的阈值3.3微克/分升预测了25例自杀中的17例(敏感性为68%),相比之下,下午4点常规阈值5微克/分升时预测了25例自杀中的15例(敏感性60%)。在男性自杀未遂者中,病理性DST结果的较低阈值(3.3微克/分升)使优势比从6.7变为18。在女性自杀未遂者中,较高的阈值(7.3微克/分升)优化了DST作为自杀预测生物学检测的价值,表明存在性别差异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验